National Institute of Allergy and Infectious Diseases (NIAID): Granuloma trials

The registry lists 14 Granuloma studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 1 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 6Phase 2 3Phase 3 1Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and GranulocytesRecruitingNCT00001405
• Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant CyclophosphamideTerminatedNCT02282904Phase 1/2Results posted
• Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous DiseaseTerminatedNCT01147042Phase 4Results posted
• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseTerminatedNCT00325078Phase 1/2Results posted
• Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995Status unknownNCT02082353
• Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous DiseaseWithdrawnNCT01851460Phase 1
• Gene Therapy for Chronic Granulomatous DiseaseTerminatedNCT00394316Early Phase 1
• Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantCompletedNCT00092937Phase 1
• Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of CareCompletedNCT00023192Phase 3
• Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous DiseaseCompletedNCT00006417Phase 2
• Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related DisordersCompletedNCT00005933
• Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous DiseaseCompletedNCT00001765Phase 1
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-upCompletedNCT00001476Phase 1
• A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of ChildhoodCompletedNCT00001317Phase 4